Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-261852
Filing Date
2013-06-18
Accepted
2013-06-18 06:07:57
Documents
5
Period of Report
2013-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d555745d6k.htm 6-K 10432
2 EX-99.1 d555745dex991.htm EX-99.1 43280
3 GRAPHIC g555745ex99_1pg1a.jpg GRAPHIC 27268
4 GRAPHIC g555745ex99_1pg1b.jpg GRAPHIC 4363
5 GRAPHIC g555745logo.jpg GRAPHIC 13779
  Complete submission text file 0001193125-13-261852.txt   117692
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 13918146
SIC: 2834 Pharmaceutical Preparations